Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 245

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancer

Open access
Nguyen, Han Christine Ngoc, Xie, Wanling, Yang, Ming, Hsieh, Chen‐Lin, Drouin, Sarah, Lee, Gwo‐Shu Mary, Kantoff, Philip W. · 2013 · The Prostate

Abstract

BACKGROUND: Recent studies show that microRNAs (miRNAs), small non‐coding RNAs that negatively regulate gene expression, may have potential for monitoring cancer status. We investigated circulating miRNAs in prostate cancer that may be associated with the progression of hormone‐sensitive primary tumors to metastatic castration resistant prostate cancer (CRPC) after androgen deprivation therapy. METHODS: Using genome‐wide expression profiling by TaqMan Human MicroRNA Arrays (Applied Biosystems) and/or quantitative real‐time polymerase chain reaction, we compared the expression levels of miRNAs in serum samples from 28 patients of low‐risk localized disease, 30 of high‐risk localized disease and 26 of metastatic CRPC. RESULTS: We demonstrated that serum samples from patients of low risk, localized prostate cancer and metastatic CRPC patients exhibit distinct circulating miRNA signatures. MiR‐375, miR‐378*, and miR‐141 were significantly over‐expressed in serum from CRPC patients compared with serum from low‐risk localized patients, while miR‐409‐3p was significantly under‐expressed. In prostate primary tumor samples, miR‐375 and miR‐141 also had significantly higher expression levels compared with those in normal prostate tissue. CONCLUSIONS: Circulating miRNAs, particularly miR‐375, miR‐141, miR‐378*, and miR‐409‐3p, are differentially expressed in serum samples from prostate cancer patients. In the search for improved minimally invasive methods to follow cancer pathogenesis, the correlation of disease status with the expression patterns of circulating miRNAs may indicate the potential importance of circulating miRNAs as prognostic markers for prostate cancer progression. Prostate 73: 346–354, 2013. © 2012 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pros.22572

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 245

Metadata

Authors
Nguyen, H. C. N., Xie, W., Yang, M., Hsieh, C., Drouin, S., Lee, G. M., & Kantoff, P. W.
Venue
The Prostate
Publisher
Wiley
Published
2012-08-10
Volume
73
Issue
4
Pages
346-354
ISSN
  • 0270-4137 (ISSN-L)
  • 1097-0045
OpenAlex
W2062786725
Cited by
245
References
3
FWCI
8.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancer. https://app.cochat.ai/papers/10.1002/pros.22572
The paper
Nguyen, H. C. N., Xie, W., Yang, M., Hsieh, C., Drouin, S., Lee, G. M., & Kantoff, P. W. (2013). Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancer. The Prostate. https://doi.org/10.1002/pros.22572

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.